Assignment Prompt & Instructions
**files (1)**
– ## POST11-2.docx
**## POST11-2.docx**
QUESTION
**HPI:** PF is a 21-year-old college student who presents with suicidal ideation. She has been depressed and despondent for the last three days. One week ago, she was happy and outgoing. She states that she recently told her college professor that she was considering ending her life. The patient states she often feels like she is alone in the world. Lately, she has been arguing with her new roommate.
**Collateral:** Her mother reports she has a history of unstable interpersonal relationships, fear of abandonment, and rapid mood changes.
**PPH:** She describes three prior suicide attempts(Multiple scars are found on her left wrist)
**Assessment:** Borderline personality disorder
· What is the first-line treatment for BPD?
· What can be done from a psychopharmacological perspective? – Consider medication classes and what symptoms are being targeted.
· Discuss the limitations of treatment for borderline personality disorder.
Student response: Borderline personality disorder (BPD) has a high mortality rate and functional impairment which can be challenging to treat because symptoms often involve multiple areas of a person’s life, including mood, relationships, impulsivity, and self-image (Leichsenring et al., 2024). In this case, PF demonstrates several characteristic features of BPD, including unstable relationships, fear of abandonment, rapid mood changes, recurrent suicidal behavior, and self-harm (Leichsenring et al., 2024).
The first-line treatment for BPD is psychotherapy lasting longer than 3 months, particularly dialectical behavior therapy (DBT) (Leichsenring et al., 2024). DBT was specifically developed for individuals with BPD and has proven to be more effective than SSRIs when it comes to suicide attempts and ideations, lowering mortality rates (Richmond, 2025). DBT focuses on skills such as emotional regulation, distress tolerance, mindfulness, and interpersonal effectiveness (Leichsenring et al., 2024). These skills can be especially important for someone like PF, who appears to have difficulty managing intense emotions and interpersonal conflict. Given her current suicidal ideation and history of attempts, immediate safety and suicide-risk assessment would obviously be the priority before focusing on long-term treatment.
Medication is a little more complicated because there is no medication that specifically treats BPD itself, and DBT is proven to be much more effective in treatment than pharmaceuticals (Richmond, 2025). Instead, medications such as SSRIs may be used to target individual symptoms or co-occurring psychiatric conditions such as depression (Richmond, 2025). Sedatives and antipsychotics are effective in managing a crisis situation but typically are only used acutely to stabilize and have not been proven effective for long-term treatment of BPD (Leichsenring et al., 2024). Medications should be prescribed cautiously, especially in patients with recurrent suicidal behavior or substance abuse history, and polypharmacy should be avoided whenever possible.
One major limitation in treating BPD is that improvement typically requires long-term participation and commitment to DBT for at least a year, however some programs have a 6-month course which has also proven to be effective (Biskin & Paris, 2012). Fear of abandonment, difficulty trusting others, emotional reactivity, and unstable relationships can also affect the therapeutic relationship itself (Preti et al., 2023). Stigma and social media stereotypes also play a huge role in BPD treatment outcomes and barriers. Social media is glorifying mental illness, making disorders such as BPD appear “trendy”, causing people to dangerously self-diagnose (Ahuja & Fichadia, 2024). The romanticizing of BPD on platforms such as TikTok are causing people to adapt to certain negative traits associated with this debilitating disorder without fully understanding the negative consequences, this also increases negative stigma (Ahuja & Fichadia, 2024). It is important to encourage community and peer support for patients with BPD, but it is also significantly important to discuss the dangers of these social media traps which can trigger negative responses and undo progress in therapy.
**References**
Ahuja, J., & Fichadia, P. A. (2024). Concerns regarding the glorification of mental illness on social media.
_Cureus_,
_16_(3), e56631.
[https://doi.org/10.7759/cureus.56631](https://doi.org/10.7759/cureus.56631)
Biskin, R. S., & Paris, J. (2012). Management of borderline personality disorder.
_CMAJ : Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne_,
_184_(17), 1897–1902.
[https://doi.org/10.1503/cmaj.112055](https://doi.org/10.1503/cmaj.112055)
Leichsenring, F., Fonagy, P., Heim, N., Kernberg, O. F., Leweke, F., Luyten, P., Salzer, S., Spitzer, C., & Steinert, C. (2024). Borderline personality disorder: A comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies.
_World Psychiatry : Official Journal of the World Psychiatric Association (WPA)_,
_23_(1), 4–25. https://doi.org/10.1002/wps.21156
Preti, E., Richetin, J., Poggi, A., & Fertuck, E. (2023). A model of trust processes in borderline personality disorder: A systematic review.
_Current Psychiatry Reports_,
_25_(11), 555–567.
[https://doi.org/10.1007/s11920-023-01468-y](https://doi.org/10.1007/s11920-023-01468-y)
Richmond, L. M. (2025). DBT works better than SSRIs for adults with borderline personality disorder.
_Psychiatric News, 60_(12).
[_https://doi.org/10.1176/appi.pn.2025.12.12.35_](https://doi.org/10.1176/appi.pn.2025.12.12.35)
**## POST11-2.docx**
QUESTION
**HPI:** PF is a 21-year-old college student who presents with suicidal ideation. She has been depressed and despondent for the last three days. One week ago, she was happy and outgoing. She states that she recently told her college professor that she was considering ending her life. The patient states she often feels like she is alone in the world. Lately, she has been arguing with her new roommate.
**Collateral:** Her mother reports she has a history of unstable interpersonal relationships, fear of abandonment, and rapid mood changes.
**PPH:** She describes three prior suicide attempts(Multiple scars are found on her left wrist)
**Assessment:** Borderline personality disorder
· What is the first-line treatment for BPD?
· What can be done from a psychopharmacological perspective? – Consider medication classes and what symptoms are being targeted.
· Discuss the limitations of treatment for borderline personality disorder.
Student response: Borderline personality disorder (BPD) has a high mortality rate and functional impairment which can be challenging to treat because symptoms often involve multiple areas of a person’s life, including mood, relationships, impulsivity, and self-image (Leichsenring et al., 2024). In this case, PF demonstrates several characteristic features of BPD, including unstable relationships, fear of abandonment, rapid mood changes, recurrent suicidal behavior, and self-harm (Leichsenring et al., 2024).
The first-line treatment for BPD is psychotherapy lasting longer than 3 months, particularly dialectical behavior therapy (DBT) (Leichsenring et al., 2024). DBT was specifically developed for individuals with BPD and has proven to be more effective than SSRIs when it comes to suicide attempts and ideations, lowering mortality rates (Richmond, 2025). DBT focuses on skills such as emotional regulation, distress tolerance, mindfulness, and interpersonal effectiveness (Leichsenring et al., 2024). These skills can be especially important for someone like PF, who appears to have difficulty managing intense emotions and interpersonal conflict. Given her current suicidal ideation and history of attempts, immediate safety and suicide-risk assessment would obviously be the priority before focusing on long-term treatment.
Medication is a little more complicated because there is no medication that specifically treats BPD itself, and DBT is proven to be much more effective in treatment than pharmaceuticals (Richmond, 2025). Instead, medications such as SSRIs may be used to target individual symptoms or co-occurring psychiatric conditions such as depression (Richmond, 2025). Sedatives and antipsychotics are effective in managing a crisis situation but typically are only used acutely to stabilize and have not been proven effective for long-term treatment of BPD (Leichsenring et al., 2024). Medications should be prescribed cautiously, especially in patients with recurrent suicidal behavior or substance abuse history, and polypharmacy should be avoided whenever possible.
One major limitation in treating BPD is that improvement typically requires long-term participation and commitment to DBT for at least a year, however some programs have a 6-month course which has also proven to be effective (Biskin & Paris, 2012). Fear of abandonment, difficulty trusting others, emotional reactivity, and unstable relationships can also affect the therapeutic relationship itself (Preti et al., 2023). Stigma and social media stereotypes also play a huge role in BPD treatment outcomes and barriers. Social media is glorifying mental illness, making disorders such as BPD appear “trendy”, causing people to dangerously self-diagnose (Ahuja & Fichadia, 2024). The romanticizing of BPD on platforms such as TikTok are causing people to adapt to certain negative traits associated with this debilitating disorder without fully understanding the negative consequences, this also increases negative stigma (Ahuja & Fichadia, 2024). It is important to encourage community and peer support for patients with BPD, but it is also significantly important to discuss the dangers of these social media traps which can trigger negative responses and undo progress in therapy.
**References**
Ahuja, J., & Fichadia, P. A. (2024). Concerns regarding the glorification of mental illness on social media.
_Cureus_,
_16_(3), e56631.
[https://doi.org/10.7759/cureus.56631](https://doi.org/10.7759/cureus.56631)
Biskin, R. S., & Paris, J. (2012). Management of borderline personality disorder.
_CMAJ : Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne_,
_184_(17), 1897–1902.
[https://doi.org/10.1503/cmaj.112055](https://doi.org/10.1503/cmaj.112055)
Leichsenring, F., Fonagy, P., Heim, N., Kernberg, O. F., Leweke, F., Luyten, P., Salzer, S., Spitzer, C., & Steinert, C. (2024). Borderline personality disorder: A comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies.
_World Psychiatry : Official Journal of the World Psychiatric Association (WPA)_,
_23_(1), 4–25. https://doi.org/10.1002/wps.21156
Preti, E., Richetin, J., Poggi, A., & Fertuck, E. (2023). A model of trust processes in borderline personality disorder: A systematic review.
_Current Psychiatry Reports_,
_25_(11), 555–567.
[https://doi.org/10.1007/s11920-023-01468-y](https://doi.org/10.1007/s11920-023-01468-y)
Richmond, L. M. (2025). DBT works better than SSRIs for adults with borderline personality disorder.
_Psychiatric News, 60_(12).
[_https://doi.org/10.1176/appi.pn.2025.12.12.35_](https://doi.org/10.1176/appi.pn.2025.12.12.35)